Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
Purpose We aimed to systematically evaluate the efficacy and safety of adalimumab biosimilar agents in the treatment of moderate-to-severe plaque psoriasis, in order to provide evidence-based reference data for clinical medicine. Materials and Methods Five databases were searched by electronic retri...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2023-12-01
|
| Sarja: | Journal of Dermatological Treatment |
| Aiheet: | |
| Linkit: | http://dx.doi.org/10.1080/09546634.2023.2249145 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|